Current Treatment Options in Allergy

Top Research Topics at Current Treatment Options in Allergy?

The discussions in the journal mainly cover the fields of Allergy, Immunology, Intensive care medicine, Dermatology and Asthma. In addition to Allergy research, it aims to explore topics under Disease and Immunotherapy. The journal connects research in Immunology with the related topic of Clinical trial.

Current Treatment Options in Allergy holds forums on Intensive care medicine that merges themes from other disciplines such as Provocation test, Desensitization (medicine), Omalizumab, Public health and Drug. The study of Contact dermatitis and how it intertwines with concepts under Cosmetics were explored in the presented Dermatology research. The Asthma research dealing mostly with Occupational asthma is the focus of Current Treatment Options in Allergy.

The concepts on Anaphylaxis presented in the journal can also apply to other research fields, including Mast cell, Tryptase, Epinephrine, Anesthesia and Epidemiology. Allergen immunotherapy and Slit are closely related fields of research discussed in the journal. The in-depth study on Immunoglobulin E also explores topics in the intersecting field of Sensitization.

• Allergy (79.72%)
• Immunology (38.79%)
• Intensive care medicine (27.76%)

What are the most cited papers published in the journal?

• Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy (52 citations)
• Therapeutic Patient Education (29 citations)
• Is The Allergen Really Needed in Allergy Immunotherapy (29 citations)

Research areas of the most cited articles at Current Treatment Options in Allergy:

The journal articles facilitate discussions on Allergy, Immunology, Immunotherapy, Allergen and Allergen immunotherapy. Most of the Immunology studies addressed in the journal publications also intersect with Disease. The studies on Allergen discussed at the published papers can also contribute to research in the domains of Immunoglobulin E and T cell.

What topics the last edition of the journal is best known for?

• Internal medicine
• Disease
• Surgery

The previous edition focused in particular on these issues:

Current Treatment Options in Allergy focuses on Allergy, Intensive care medicine, Anaphylaxis, Food allergy and Disease. More specifically, the research on Allergy in the journal is related to Allergen. While work presented in Current Treatment Options in Allergy provided substantial information on Intensive care medicine, it also covered topics in Tolerability, Adverse effect, Radiocontrast Media, Overdiagnosis and Immunotherapy.

Anaphylaxis research presented in Current Treatment Options in Allergy encompasses a variety of subjects, including Epinephrine, Autoinjector, Allergic reaction and Medical emergency. Current Treatment Options in Allergy explores themes in Food allergy like Epinephrine autoinjector and links them with other fields of study like Pandemic. The tackled Disease research is interrelated with Exposome which concerns subjects like Immunology.

The most cited articles from the last journal are:

• The Role of the Environment and Exposome in Atopic Dermatitis. (2 citations)
• Management of Anaphylaxis During the SARS-CoV-2 Pandemic. (2 citations)
• The Use of Bruton’s Tyrosine Kinase Inhibitors to Treat Allergic Disorders (1 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Current Treatment Options in Allergy (based on the number of publications) are:

• María José Torres (6 papers) published 1 paper at the last edition,
• Tahia D. Fernandez (6 papers) absent at the last edition,
• David A. Khan (5 papers) absent at the last edition,
• Riccardo Asero (5 papers) absent at the last edition,
• Pedro Giavina-Bianchi (5 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Current Treatment Options in Allergy (based on the number of publications) are:

• Boston Children's Hospital (7 papers) published 2 papers at the last edition,
• University of Texas Southwestern Medical Center (7 papers) absent at the last edition,
• University of São Paulo (7 papers) absent at the last edition,
• Charité (5 papers) absent at the last edition,
• University of California, Los Angeles (5 papers) published 2 papers at the last edition, 1 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 10.53% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 29.41% were posted by at least one author from the top 10 institutions publishing in the journal. Another 5.88% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 41.18% of all publications and 23.53% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.